Nektar Therapeutics prices upsized $325M public offering at $92.00 per share

AI Briefing

• – Nektar Therapeutics upsizes public offering to $325M, selling 3.53M shares at $92.00 per share.
• – Company's initial public offering price was $75.00 per share.
• – Upsized offering is a significant increase from the initially proposed $250M.